| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 658222 | 68313 | EBASTINA VIR 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA VIR 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68313/68313_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68313/68313_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2007-01-08 | 1 | 1 | 1 | 2007-01-08 | 2007-01-08 | 1 | 2016-05-18 | View Edit Delete | ||||||||||||
| 658403 | 68433 | AMLODIPINO VIR 5 mg COMPRIMIDOS EFG | AMLODIPINO VIR 5 mg COMPRIMIDOS EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68433/68433_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68433/68433_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2007-01-30 | 1 | 1 | 1 | 2007-01-30 | 2007-01-30 | 0 | 2011-06-08 | View Edit Delete | ||||||||||||
| 654849 | 06370011 | EXFORGE 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06370011/06370011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06370011/06370011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2007-02-08 | 1 | 1 | 1 | 2007-02-08 | 2014-03-17 | 0 | 2013-11-12 | 658408, 663429 | View Edit Delete | |||||||||||
| 654850 | 06370019 | EXFORGE 10 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE 10 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06370019/06370019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06370019/06370019_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2007-02-08 | 1 | 1 | 1 | 2007-02-08 | 2014-03-17 | 0 | 2013-11-12 | 658409, 663430 | View Edit Delete | |||||||||||
| 654851 | 09569002 | EXFORGE HCT 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569002/09569002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569002/09569002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664335 | View Edit Delete | |||||||||||
| 654852 | 09569014 | EXFORGE HCT 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569014/09569014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569014/09569014_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664336 | View Edit Delete | |||||||||||
| 654853 | 09569026 | EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569026/09569026_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569026/09569026_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664337 | View Edit Delete | |||||||||||
| 654854 | 09569038 | EXFORGE HCT 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569038/09569038_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569038/09569038_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664338 | View Edit Delete | |||||||||||
| 655134 | 62024 | VOLTAREN RETARD 75 mg COMPRIMIDOS DE LIBERACION MODIFICADA | VOLTAREN RETARD 75 mg COMPRIMIDOS DE LIBERACION MODIFICADA , 40 comprimidos | 75 mg | 5 | 40 | 10 | 40 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62024/62024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62024/62024_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-10-01 | 1 | 2011-10-06 | View Edit Delete | ||||||||||||
| 657353 | 62206 | CO-DIOVAN 80 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CO-DIOVAN 80 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (AL/PVC/PVDC) | 80 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos (AL/PVC/PVDC) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62206/62206_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62206/62206_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-10-01 | 0 | 2011-10-06 | View Edit Delete | ||||||||||||
| 656551 | 66263 | CITALOPRAM COMBIX 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CITALOPRAM COMBIX 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66263/66263_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66263/66263_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2004-08-23 | 1 | 1 | 1 | 2013-02-13 | 2013-02-13 | 1 | 2026-03-05 | 827584, 999764, 653350 | View Edit Delete | |||||||||||
| 656556 | 64322 | SIMVASTATINA COMBIX 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SIMVASTATINA COMBIX 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64322/64322_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64322/64322_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2001-10-25 | 1 | 1 | 1 | 2001-10-25 | 2007-07-09 | 1 | 2026-02-10 | 897249, 769844, 798645, 999952, 653351 | View Edit Delete | |||||||||||
| 658118 | 68248 | EBASTINA COMBIX 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA COMBIX 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 20 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68248/68248_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68248/68248_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2006-12-13 | 1 | 1 | 1 | 2006-12-13 | 2006-12-13 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 658119 | 68249 | EBASTINA COMBIX 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA COMBIX 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68249/68249_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68249/68249_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2006-12-13 | 1 | 1 | 1 | 2006-12-13 | 2006-12-13 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 654802 | 08442011 | PRADAXA 150 mg CAPSULAS DURAS | PRADAXA 150 mg CAPSULAS DURAS, 60 cápsulas | 150 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08442011/08442011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08442011/08442011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | BOEHRINGER INGELHEIM ESPANA S.A. | 2011-08-22 | 1 | 1 | 1 | 2011-08-22 | 2013-08-08 | 1 | 2014-01-02 | 683358 | View Edit Delete | |||||||||||
| 654832 | 64796 | SPIRIVA 18 MICROGRAMOS POLVO PARA INHALACION | SPIRIVA 18 MICROGRAMOS POLVO PARA INHALACION , 1 inhalador + 30 cápsulas | 10 microgramos/dosis | 5 | 30 | 8 | 1 inhalador + 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64796/64796_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64796/64796_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | BOEHRINGER INGELHEIM ESPANA S.A. | 2002-05-23 | 1 | 1 | 1 | 2002-05-23 | 2013-12-09 | 1 | 2014-01-02 | 751511 | View Edit Delete | |||||||||||
| 656578 | 98090006 | MICARDIS 80 MG COMPRIMIDOS | MICARDIS 80 MG COMPRIMIDOS, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98090006/98090006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98090006/98090006_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | BOEHRINGER INGELHEIM ESPANA S.A. | 1999-03-01 | 1 | 1 | 1 | 1999-03-01 | 2007-07-10 | 1 | 2011-10-25 | 727073 | View Edit Delete | |||||||||||
| 656581 | 02213007 | MICARDISPLUS 80 mg/12,5 mg COMPRIMIDOS | MICARDISPLUS 80 mg/12,5 mg COMPRIMIDOS, 28 comprimidos | 80 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02213007/02213007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02213007/02213007_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | BOEHRINGER INGELHEIM ESPANA S.A. | 2002-07-17 | 1 | 1 | 1 | 2002-07-17 | 2007-07-10 | 1 | 2011-10-25 | 826305 | View Edit Delete | |||||||||||
| 654856 | 06371019 | DAFIRO 10 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | DAFIRO 10 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06371019/06371019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06371019/06371019_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ESTEVE PHARMACEUTICALS S.A. | 2007-04-02 | 1 | 1 | 1 | 2007-04-02 | 2014-03-17 | 0 | 2011-02-24 | 671927 | View Edit Delete | |||||||||||
| 654857 | 06371011 | DAFIRO 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | DAFIRO 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06371011/06371011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06371011/06371011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ESTEVE PHARMACEUTICALS S.A. | 2007-04-02 | 1 | 1 | 1 | 2007-04-02 | 2014-03-17 | 0 | 2011-02-24 | 671928 | View Edit Delete |
Page 121 of 1035, showing 20 records out of 20697 total, starting on record 2401, ending on 2420